Image of hexagons in various sizes

Mark Schenerman Elected; Sarah Kennett Reelected to CASSS Board Of Directors

Home / News

May 22, 2023
Company logo with text 'CASSS Sharing Science Solutions'

CASSS – Sharing Science Solutions is pleased to announce Mark Schenerman has been elected and Sarah Kennett reelected to the Board of Directors. They will join the twelve-member board responsible for governance and strategic direction of the association. Mark and Sarah are both honored to have been elected by their peers to the CASSS Board of Directors

Reflecting on why he chose to seek a seat on the board again, Mark says, “He is deeply rooted in CASSS’ history but looking forward to its future…and working on key priorities for the future.” 

Sarah’s reelection to the board she looks forward to, “Like much of the post-COVID world, CASSS is navigating turbulent times. The Board, along with the CASSS staff, are called to 'think bigger' and make adjustments to our portfolio; to consider new opportunities and new formatting for our meetings. I am excited to continue contributing with my experience.”

Mark Schenerman is currently President of CMC Biotech-MAS Consulting and recently became the Graduate Program Director in Biotechnology for University of Maryland Baltimore County. Prior to that, Schenerman spent more than 20 years in various roles in pharmaceutical development and regulatory processes at MedImmune. After receiving his Bachelor of Science degree in medical technology from the University of Maryland Baltimore, Mark received his PhD from the University of Florida.

Mark’s volunteer positions with CASSS are extensive but highlights include serving as the Industry Co-Chair of WCBP 2011, committee member for CMC Strategy Forums, and helping start many programs including Bioassays, Higher Order Structure, DC Discussion Group, and CASSS’ Consultants Network. He has also spearheaded CASSS’ involvement in the Hopkins Biotech Network Mentor Program. He was also recently recognized as a CASSS Distinguished Fellow for his outstanding contributions to CASSS, our community, and the industry overall.

Sarah Kennett is currently Executive Portfolio Director, Pharma Technical Regulatory at Genentech. Prior to that, Kennett spent more than 10 years in various roles at the US FDA. After receiving her Bachelor of Science degree in molecular and cell biology from The Pennsylvania State University, Sarah received her Ph.D. from Duke University.

Sarah’s volunteer positions with CASSS are extensive but highlights include serving as committee member for the North America CMC Strategy Fora and CE in the Biotechnology & Pharmaceutical Industries: Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules and, more recently, as a member of the WCBP committee. She was also the recipient of the CASSS CE Pharm Award in 2016. This award recognizes individuals with sustained and significant contributions in the practical application of CE to the analysis of Biotechnology and Pharmaceutical products.